In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021
- 1 January 1986
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 17 (3-4) , 368-370
- https://doi.org/10.1007/bf01982649
Abstract
The effects of BN 52021, a new specific paf-acether receptor antagonist and the total Ginkgo biloba extract (GBE 761) from which this product was isolated, were studied in the rat on paf-acether-induced permeability and cell number changes and on endotoxin-induced lethality. Their activities were compared to those of cycloxygenase, 5-lipoxygenase and phospholipase A2 inhibitors. BN 52021 given s.c. or orally exerted a dose-related inhibition of paf-acether deleterious effects as well as of endotoxin lethality whereas the other drugs tested were poorly effective. These results strongly suggest paf-acether involvement in endotoxic and septic shock.Keywords
This publication has 4 references indexed in Scilit:
- ShockArchives of internal medicine (1960), 1984
- Shock. Diagnosis and managementArchives of internal medicine (1960), 1984
- Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious ratsBritish Journal of Pharmacology, 1984
- Intensive care treatment in septic shock.1983